Biocon Limited (BIOCON)
BSE
370.90
-0.10 (-0.03%)
Closed
Oct 1, 2026
Day's Range
363.55374.20
52 wk Range
337.95447.00
Financial Statements - BIOCON - Biocon Limited
Revenue
167.79B▲ 11.5%
Net Income
3.68B▼ 74.2%Net Margin 2.2%
EBITDA
36.52B▲ 8.7%
Free Cash Flow
823.00M▼ 95.2%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 167.79B | 150.52B | 141.95B | 109.34B | 80.24B | 70.07B |
| Cost of Goods | 56.94B | 51.98B | 49.06B | 36.66B | 27.23B | 22.45B |
| Gross Profit | 110.85B | 98.54B | 92.89B | 72.67B | 53.01B | 47.62B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 17.22B | 16.25B | 13.50B | 12.34B | 10.67B | 6.04B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 4.47B | 18.86B | 15.25B | 8.97B | 9.83B | 10.67B |
| Income Tax | 791M | 4.57B | 2.27B | 2.54B | 2.11B | 2.21B |
| Net Income | 3.68B | 14.29B | 12.97B | 6.43B | 7.71B | 8.46B |
| EPS Basic | 2.82 | 8.46 | 8.55 | 3.88 | 5.44 | 6.24 |
| EPS Diluted | 2.82 | 8.46 | 8.54 | 3.87 | 5.42 | 6.19 |
| Basic Shares Outstanding | 1.36B | 1.19B | 1.19B | 1.19B | 1.19B | 1.18B |
| Diluted Shares Outstanding | 1.36B | 1.19B | 1.19B | 1.19B | 1.19B | 1.18B |
| Ebit | 14.12B | 27.74B | 24.99B | 13.16B | 10.50B | 11.25B |
| Ebitda | 36.52B | 33.59B | 30.31B | 25.29B | 19.64B | 16.65B |
| Net Income Continuous Operations | 3.68B | 14.29B | 12.97B | 6.43B | 7.71B | 8.46B |
| Minority Interests | 168M | -4.16B | -2.75B | -1.80B | -1.23B | -1.05B |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
